These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17693214)

  • 1. Reliability and validity of the self-efficacy expectations and outcome expectations after implantable cardioverter defibrillator implantation scales.
    Dougherty CM; Johnston SK; Thompson EA
    Appl Nurs Res; 2007 Aug; 20(3):116-24. PubMed ID: 17693214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical function, psychological adjustment, and self-efficacy following sudden cardiac arrest and an initial implantable cardioverter defibrillator (ICD) in a social cognitive theory intervention: secondary analysis of a randomized control trial.
    Dougherty CM; Liberato ACS; Streur MM; Burr RL; Kwan KY; Zheng T; Auld JP; Thompson EA
    BMC Cardiovasc Disord; 2022 Aug; 22(1):369. PubMed ID: 35948889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
    Habibović M; Pedersen SS; van den Broek KC; Denollet J
    Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient plus partner trial: A randomized controlled trial of 2 interventions to improve outcomes after an initial implantable cardioverter-defibrillator.
    Dougherty CM; Thompson EA; Kudenchuk PJ
    Heart Rhythm; 2019 Mar; 16(3):453-459. PubMed ID: 30340060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instruments to assess self-efficacy among people with cardiovascular disease: A COSMIN systematic review.
    Turan Kavradim S; Yangöz ŞT; Canli Ozer Z; Boz I
    Int J Clin Pract; 2020 Nov; 74(11):e13606. PubMed ID: 33166049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intervention mediating effects of self-efficacy on patient physical and psychological health following ICD implantation.
    Liberato ACS; Thompson EA; Dougherty CM
    J Behav Med; 2021 Dec; 44(6):842-852. PubMed ID: 34302228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decisional balance among potential implantable cardioverter defibrillator recipients: development of the ICD-decision analysis scale (ICD-DAS).
    Hazelton AG; Sears SF; Ford J; Cahill J; Nekkanti R; Deantonio H; Ottoboni L; Norton L; Wang P
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):63-72. PubMed ID: 24219117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do positive health expectations and optimism relate to quality-of-life outcomes for the patient with an implantable cardioverter defibrillator?
    Sears SF; Serber ER; Lewis TS; Walker RL; Conners N; Lee JT; Curtis AB; Conti JB
    J Cardiopulm Rehabil; 2004; 24(5):324-31. PubMed ID: 15602153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community.
    Narayanan K; Reinier K; Uy-Evanado A; Teodorescu C; Chugh H; Marijon E; Gunson K; Jui J; Chugh SS
    Circulation; 2013 Oct; 128(16):1733-8. PubMed ID: 24048201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey.
    Versteeg H; Starrenburg A; Denollet J; Palen Jv; Sears SF; Pedersen SS
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):283-93. PubMed ID: 22229519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
    Burns JL; Serber ER; Keim S; Sears SF
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an instrument to measure glaucoma medication self-efficacy and outcome expectations.
    Sleath B; Blalock SJ; Robin A; Hartnett ME; Covert D; DeVellis B; Giangiacomo A
    Eye (Lond); 2010 Apr; 24(4):624-31. PubMed ID: 19648896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.